Načítá se...

Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 β-lactamases: Raman crystallographic evidence

Tazobactam, sulbactam, and clavulanic acid are the only β-lactamase inhibitors in clinical use. Comparative inhibitory activities of clavulanic acid, sulbactam, and tazobactam against clinically important β-lactamases conclude that tazobactam is superior to both clavulanic acid and sulbactam. Thus f...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kalp, Matthew, Totir, Monica A., Buynak, John D., Carey, Paul R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2661619/
https://ncbi.nlm.nih.gov/pubmed/19161282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ja808311s
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!